Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Der Internist|October 13, 2006
[Water and electrolyte disturbances in critical care]T Matthäus, R Schnitzler, P Weithofer, et al.
Plos One|November 25, 2015
Open LED Illuminator: A Simple and Inexpensive LED Illuminator for Fast Multicolor Particle Tracking in NeuronsJens B Bosse, Nikhila S Tanneti, Ian B Hogue, et al.
Zeitschrift Fur Gastroenterologie|October 23, 2013
Is the transnasal access for esophagogastroduodenoscopy in routine use equal to the transoral route? A prospective, randomized trialJ Knuth, D E Kunze, C Benz, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2013
In vivo imaging of alphaherpesvirus infection reveals synchronized activity dependent on axonal sorting of viral proteinsAndrea E Granstedt, Jens B Bosse, Stephan Y Thiberge, et al.
Kidney International. Supplement|February 25, 1998
Therapeutic options for critically ill patients suffering from progressive lupus nephritis or Goodpasture's syndromeF Merkel, K O Netzer, O Gross, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 casesF Merkel, O Pullig, M Marx, et al.
Plos One|April 16, 2014
A modified screening system for loss-of-function and dominant negative alleles of essential MCMV genesMadlen Pogoda, Jens B Bosse, Karl-Klaus Conzelmann, et al.
Alimentary Pharmacology & Therapeutics|September 3, 1998
Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitisW Kruis, J W Brandes, S Schreiber, et al.
European Journal of Pain (London, England)|June 23, 2017
A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160/80 mg daily) vs oxycodone PRD Dupoiron, A Stachowiak, O Loewenstein, et al.
Schmerz (Berlin, Germany)|June 1, 2005
[Oral controlled-release oxycodone for the treatment of chronic pain. Data from 4196 patients]J Gaertner, M Frank, B Bosse, et al.
Pageof 11